SELE and Miyoshi myopathy: In this respect, we have previously shown that MM cells enriched for the expression of selectin ligands display an aggressive phenotype characterized by a complete resistance to bortezomib in vivo, which can be reverted by blocking E-selectin with small glycomimetic molecules or by inhibiting sialyltransferases, which are involve in the generation of selectin ligands25,26.